A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck

BACKGROUND: Induction chemotherapy (IC) in locally advanced squamous cell carcinoma of the head and neck (LA‐SCCHN) often compromises compliance with subsequent chemoradiotherapy (CRT), which negatively affects outcomes. Here, we assessed the combination of paclitaxel (PTX), carboplatin (CBDCA), and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Med
Autores principales: Enokida, Tomohiro, Ogawa, Takenori, Homma, Akihiro, Okami, Kenji, Minami, Shujiro, Nakanome, Ayako, Shimizu, Yasushi, Maki, Daisuke, Ueda, Yuri, Fujisawa, Takao, Motegi, Atsushi, Ohkoshi, Akira, Taguchi, Jun, Ebisumoto, Koji, Nomura, Shogo, Okano, Susumu, Tahara, Makoto
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7050099/
https://ncbi.nlm.nih.gov/pubmed/31943834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2852
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares